Novel nasal spray effectively prevents influenza infection
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
List view / Grid view
The nasal spray reduced influenza virus levels by >99.99 percent, which could safeguard public health if validated in humans.
The researchers discovered that anti-PD-1 autoantibodies influence the outcome of Atezo/Bev therapy for hepatocellular carcinoma.
Following high-throughput drug screening of the tumour organoids, an effective FDA-approved treatment was identified.
Scientists have developed a monoclonal antibody drug that could help to prevent infection from Acinetobacter baumannii.
Researchers have identified over 3,000 harmful genetic changes that could disrupt normal RAD51C function.
ICR researchers have discovered that prostate cancer patients with high BCL2 levels have a shorter overall survival rate.
Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials.
The model enables researchers to expand the number of tumours that they can study, increasing their ability to detect novel interactions.
The expansion of Sino Biological and BioGeometry’s strategic partnership promises to accelerate drug discovery.
This study is the first to demonstrate that NSD2 is foundational to the earliest stage of prostate cancer development.
Microbeads enabled the precise release of signal molecules at any time or location within retinal organoids.
The publicly available Human Endometrial Cell Atlas could progress the development of therapeutics for endometriosis.
The study’s findings could contribute to future therapeutic strategies to prevent chronic kidney disease.
The mRNA vaccine candidate more effectively limited symptoms and disease duration in non-human primates.
Researchers found that HD can impair early brain development through defects associated with mitochondrial dysfunction.